DK1019039T3 - Komprimeret nitroglycerintablet og fremgangsmåde til dens fremstilling - Google Patents

Komprimeret nitroglycerintablet og fremgangsmåde til dens fremstilling

Info

Publication number
DK1019039T3
DK1019039T3 DK98948293T DK98948293T DK1019039T3 DK 1019039 T3 DK1019039 T3 DK 1019039T3 DK 98948293 T DK98948293 T DK 98948293T DK 98948293 T DK98948293 T DK 98948293T DK 1019039 T3 DK1019039 T3 DK 1019039T3
Authority
DK
Denmark
Prior art keywords
nitroglycerin
tablets
stable
direct compression
compression technology
Prior art date
Application number
DK98948293T
Other languages
Danish (da)
English (en)
Inventor
Roberto L Capella
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of DK1019039T3 publication Critical patent/DK1019039T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK98948293T 1997-10-03 1998-09-16 Komprimeret nitroglycerintablet og fremgangsmåde til dens fremstilling DK1019039T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6110597P 1997-10-03 1997-10-03
PCT/US1998/019356 WO1999017766A1 (en) 1997-10-03 1998-09-16 Compressed nitroglycerin tablet and its method of manufacture

Publications (1)

Publication Number Publication Date
DK1019039T3 true DK1019039T3 (da) 2002-03-25

Family

ID=22033623

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98948293T DK1019039T3 (da) 1997-10-03 1998-09-16 Komprimeret nitroglycerintablet og fremgangsmåde til dens fremstilling

Country Status (16)

Country Link
US (1) US6500456B1 (de)
EP (1) EP1019039B1 (de)
JP (1) JP2001518500A (de)
KR (1) KR100569763B1 (de)
AT (1) ATE209911T1 (de)
AU (1) AU759018B2 (de)
BR (1) BR9812605B1 (de)
CA (1) CA2299231C (de)
DE (1) DE69802832T2 (de)
DK (1) DK1019039T3 (de)
ES (1) ES2169558T3 (de)
IL (1) IL134395A (de)
NZ (1) NZ502878A (de)
PT (1) PT1019039E (de)
TW (1) TWI228989B (de)
WO (1) WO1999017766A1 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1128817A1 (de) * 1998-10-27 2001-09-05 Biovail Technologies Ltd Mikropartikel enthaltend peg und/oder peg glycerylestern
US7815937B2 (en) * 1998-10-27 2010-10-19 Biovail Laboratories International Srl Quick dissolve compositions and tablets based thereon
US7815936B2 (en) 2001-10-30 2010-10-19 Evonik Degussa Gmbh Use of granular materials based on pyrogenically produced silicon dioxide in pharmaceutical compositions
US20040109889A1 (en) 2002-12-04 2004-06-10 Bunick Frank J. Surface treatment composition for soft substrates
US9498454B2 (en) 2003-02-24 2016-11-22 Pharmaceutical Productions Inc. Transmucosal drug delivery system
US9358296B2 (en) 2003-02-24 2016-06-07 Pharmaceutical Productions Inc. Transmucosal drug delivery system
US9254294B2 (en) 2003-02-24 2016-02-09 Pharmaceutical Productions Inc. Transmucosal hormone delivery system
CN1777411B (zh) * 2003-02-24 2013-01-02 药品生产公司 经粘膜药物递送系统
US10172810B2 (en) 2003-02-24 2019-01-08 Pharmaceutical Productions, Inc. Transmucosal ketamine delivery composition
CA2530843A1 (en) * 2003-07-01 2005-01-20 Todd Maibach Film comprising therapeutic agents
US7999003B2 (en) * 2003-08-26 2011-08-16 Mannatech, Incorporated Antioxidant compositions and methods thereto
US20060134202A1 (en) * 2004-12-22 2006-06-22 Hack Jacob C Homeopathic sublingual dosage forms and methods thereof
US8252328B2 (en) * 2006-01-06 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
US8535714B2 (en) 2006-01-06 2013-09-17 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US8753308B2 (en) 2006-01-06 2014-06-17 Acelrx Pharmaceuticals, Inc. Methods for administering small volume oral transmucosal dosage forms using a dispensing device
US9289583B2 (en) 2006-01-06 2016-03-22 Acelrx Pharmaceuticals, Inc. Methods for administering small volume oral transmucosal dosage forms using a dispensing device
US8357114B2 (en) 2006-01-06 2013-01-22 Acelrx Pharmaceuticals, Inc. Drug dispensing device with flexible push rod
US8865743B2 (en) 2006-01-06 2014-10-21 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US8202535B2 (en) 2006-01-06 2012-06-19 Acelrx Pharmaceuticals, Inc. Small-volume oral transmucosal dosage forms
US8252329B2 (en) 2007-01-05 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
US9066847B2 (en) 2007-01-05 2015-06-30 Aceirx Pharmaceuticals, Inc. Storage and dispensing devices for administration of oral transmucosal dosage forms
WO2008098195A2 (en) * 2007-02-09 2008-08-14 Todd Maibach Film comprising nitroglycerin
US20090004254A1 (en) * 2007-06-19 2009-01-01 Todd Maibach Film comprising active drugs
DK2604257T3 (en) * 2007-08-07 2017-08-28 Acelrx Pharmaceuticals Inc ORAL TRANSMUCOSAL DOSAGE FORMS INCLUDING SUFENTANIL AND TRIAZOLAM
US8945592B2 (en) * 2008-11-21 2015-02-03 Acelrx Pharmaceuticals, Inc. Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same
US20110091544A1 (en) * 2009-10-16 2011-04-21 Acelrx Pharmaceuticals, Inc. Compositions and Methods for Mild Sedation, Anxiolysis and Analgesia in the Procedural Setting
EP2990032A1 (de) 2010-08-03 2016-03-02 G. Pohl-Boskamp GmbH & Co. KG Verwendung von glyceryltrinitrat zur behandlung traumatischer ödeme
US20130331461A1 (en) 2011-02-25 2013-12-12 G. Pohl-Boskamp Gmbh & Co. Kg Stabilized Granules Containing Glyceryl Trinitrate
EP2668947B1 (de) 2012-05-31 2016-11-30 G. Pohl-Boskamp GmbH & Co. KG Arteriogeneseinduktion mit einem stickstoffmonoxid-donor, z.b. nitroglycerin
US9248099B2 (en) 2012-05-31 2016-02-02 Desmoid Aktiengesellschaft Use of stabilized granules containing glyceryl trinitrate for arteriogenesis
EP2668948A1 (de) * 2012-05-31 2013-12-04 G. Pohl-Boskamp GmbH & Co. KG Verwendung von stabilisierten Körnchen mit Glyceryltrinitrat für Arteriogenese
SG11201501415RA (en) * 2012-08-31 2015-05-28 Astellas Pharma Inc Orally administered medical composition
US10835495B2 (en) 2012-11-14 2020-11-17 W. R. Grace & Co.-Conn. Compositions containing a biologically active material and a non-ordered inorganic oxide material and methods of making and using the same
US20140303227A1 (en) * 2013-03-14 2014-10-09 Pharmaceutical Productions Inc. Transmucosal hormone delivery system
EP2878310B1 (de) 2013-11-29 2017-01-11 G. Pohl-Boskamp GmbH & Co. KG Sprühbare wässrige Zusammensetzung mit Nitroglycerin
CN105007904A (zh) * 2014-02-07 2015-10-28 科学实验室药物公司 全天然无毒舌下药物递送系统
CN113679682A (zh) * 2020-05-19 2021-11-23 珠海润都制药股份有限公司 一种硝酸甘油舌下片及其制备方法
CN114469881A (zh) * 2022-03-14 2022-05-13 河北坤安药业有限公司 一种硝酸甘油片及其制备方法
CN115154431B (zh) * 2022-07-21 2024-03-12 南京卓康医药科技有限公司 一种硝酸甘油片剂及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2357503A1 (de) * 1973-11-17 1975-05-28 Cassella Farbwerke Mainkur Ag Verfahren zur herstellung von festen carbocromen-hydrochlorid enthaltenden praeparaten
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
WO1996036330A2 (en) * 1995-05-17 1996-11-21 Cedars-Sinai Medical Center Compositions containing fatty acids for improving digestion and absorption in the small intestine
US5874418A (en) * 1997-05-05 1999-02-23 Cydex, Inc. Sulfoalkyl ether cyclodextrin based solid pharmaceutical formulations and their use

Also Published As

Publication number Publication date
CA2299231C (en) 2003-03-18
KR20010030839A (ko) 2001-04-16
ATE209911T1 (de) 2001-12-15
AU9489398A (en) 1999-04-27
CA2299231A1 (en) 1999-04-15
IL134395A (en) 2005-08-31
EP1019039B1 (de) 2001-12-05
US6500456B1 (en) 2002-12-31
ES2169558T3 (es) 2002-07-01
DE69802832D1 (de) 2002-01-17
BR9812605B1 (pt) 2009-01-13
EP1019039A1 (de) 2000-07-19
AU759018B2 (en) 2003-04-03
IL134395A0 (en) 2001-04-30
WO1999017766A1 (en) 1999-04-15
TWI228989B (en) 2005-03-11
PT1019039E (pt) 2002-04-29
DE69802832T2 (de) 2002-06-20
JP2001518500A (ja) 2001-10-16
NZ502878A (en) 2002-03-01
BR9812605A (pt) 2000-08-01
KR100569763B1 (ko) 2006-04-11

Similar Documents

Publication Publication Date Title
DK1019039T3 (da) Komprimeret nitroglycerintablet og fremgangsmåde til dens fremstilling
KR970004908B1 (ko) 기계적 응력에 대한 안정성이 증진된 약제학적 조성물 및 이의 제조방법
ATE100708T1 (de) Unbeschichtete pharmazeutische reaktionstablette.
KR900012606A (ko) 이중 정제
CA2311734A1 (en) Flash-melt oral dosage formulation
EA199700110A1 (ru) Композиция с высоким содержанием ацетаминофена для прямого прессования
RU2000123156A (ru) Быстро расщепляющаяся фармацевтическая лекарственная форма
ATE186462T1 (de) Gepirone enthaltende zusammensetzungen
NO20054897L (no) Farmasoytisk preparat inneholdende platinakompleks som aktiv substans og fremgangsmate for fremstilling derav
ATE441410T1 (de) Fenofibrattabletten
KR910011241A (ko) 정제로 직접 압착 가능한 약제학적 분말 조성물을 제조하기 위한 분무 건조법
KR100676617B1 (ko) 아목시실린 및/또는 클라불란산 또는 이의 염을 함유하는경구용 현탁정제 조성물
CA2502582A1 (en) Pharmaceutical formulation of olanzapine
CN1352558B (zh) 即释型口服用药物组合物
ATE294580T1 (de) Nasses granulationsverfahren zur herstellung von pharmazeutischen tabletten mit paroxetinhydrochlorid anhydrat
US6737419B2 (en) Benazepril hydrochloride tablet formulations
KR20010099827A (ko) 새로운 제약 조성물 및 그것의 제조방법
HU9602470D0 (en) Tablets containing captopril and process for producing them
JPH06340530A (ja) 経口投与用固体組成物
UY24437A1 (es) Procedimiento para preparar productos farmaceuticos
KR100679166B1 (ko) 안정성이 증진된 약제학적 조성물 및 그의 제조방법
KR910009287A (ko) 활성 화합물의 방출이 지연되지 않는 압착물, 이의 제조방법 및 이러한 압착물 제조용 폴리하이드록시부티르산의 용도
JP2004250398A (ja) 安定化したマレイン酸エナラプリルを含有する医薬用組成物
YU28404A (sh) Brzo topljiva formulacija za oralno doziranje
JP2004043509A (ja) プラバスタチンナトリウム錠の貯蔵安定化方法